K Glänzer

983 total citations
43 papers, 774 citations indexed

About

K Glänzer is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, K Glänzer has authored 43 papers receiving a total of 774 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 12 papers in Molecular Biology and 10 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in K Glänzer's work include Electrolyte and hormonal disorders (9 papers), Hormonal Regulation and Hypertension (8 papers) and Ion Transport and Channel Regulation (6 papers). K Glänzer is often cited by papers focused on Electrolyte and hormonal disorders (9 papers), Hormonal Regulation and Hypertension (8 papers) and Ion Transport and Channel Regulation (6 papers). K Glänzer collaborates with scholars based in Germany, Switzerland and France. K Glänzer's co-authors include Rainer Düsing, Holly Kramer, H. Vetter, Herbert J. Kramer, Jan Möhring, R Arbogast, Jayme Antunes Maciel, Jan Koch‐Weser, Hans‐Georg Predel and Burkhard Weisser and has published in prestigious journals such as Journal of Biological Chemistry, Kidney International and The American Journal of Cardiology.

In The Last Decade

K Glänzer

42 papers receiving 730 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K Glänzer Germany 17 264 200 152 130 126 43 774
J. D. H. Slater United States 17 256 1.0× 239 1.2× 134 0.9× 152 1.2× 204 1.6× 44 840
M. A. Barraclough United Kingdom 15 144 0.5× 318 1.6× 126 0.8× 136 1.0× 106 0.8× 44 693
J. C. Romero United States 15 232 0.9× 120 0.6× 118 0.8× 77 0.6× 218 1.7× 27 709
Schrier Rw United States 15 135 0.5× 191 1.0× 132 0.9× 62 0.5× 82 0.7× 43 582
U. Fox Italy 9 170 0.6× 222 1.1× 157 1.0× 102 0.8× 193 1.5× 16 757
K. M. McDonald United States 11 185 0.7× 145 0.7× 95 0.6× 65 0.5× 57 0.5× 14 514
J. C. Pelayo United States 14 178 0.7× 128 0.6× 241 1.6× 155 1.2× 128 1.0× 19 788
K Horký Czechia 16 509 1.9× 143 0.7× 320 2.1× 138 1.1× 315 2.5× 102 1.1k
Yoram Shenker United States 17 653 2.5× 222 1.1× 127 0.8× 200 1.5× 339 2.7× 40 1.2k
F. Krück Germany 15 168 0.6× 207 1.0× 230 1.5× 81 0.6× 186 1.5× 62 797

Countries citing papers authored by K Glänzer

Since Specialization
Citations

This map shows the geographic impact of K Glänzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K Glänzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K Glänzer more than expected).

Fields of papers citing papers by K Glänzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K Glänzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K Glänzer. The network helps show where K Glänzer may publish in the future.

Co-authorship network of co-authors of K Glänzer

This figure shows the co-authorship network connecting the top 25 collaborators of K Glänzer. A scholar is included among the top collaborators of K Glänzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K Glänzer. K Glänzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pabst, Stefan, Bernd Wollnik, Edyta Rohmann, et al.. (2007). A novel stop mutation truncating critical regions of the cardiac transcription factor NKX2-5 in a large family with autosomaldominant inherited congenital heart disease. Clinical Research in Cardiology. 97(1). 39–42. 31 indexed citations
2.
Uen, Sakir, Johannes Baulmann, Rainer Düsing, et al.. (2003). ST-segment depression in hypertensive patients is linked to elevations in blood pressure, pulse pressure and double product by 24-h Cardiotens monitoring. Journal of Hypertension. 21(5). 977–983. 31 indexed citations
3.
Göbel, B. O., et al.. (1991). Arterial blood pressure. Correlation with erythrocyte count, hematocrit, and hemoglobin concentration.. PubMed. 4(1 Pt 1). 14–9. 78 indexed citations
4.
Predel, Hans‐Georg, et al.. (1991). Atrial Natriuretic Peptide in Patients With Essential Hypertension. American Journal of Hypertension. 4(11). 871–879. 7 indexed citations
5.
Meyer-Lehnert, H., et al.. (1991). Effects of atrial natriuretic peptide on systemic and renal hemodynamics and renal excretory function in patients with chronic renal failure. Journal of Molecular Medicine. 69(19). 895–903. 12 indexed citations
6.
Becher, Harald, Helene von Bibra, Reinhard Schlief, et al.. (1991). Myocardial Drainage via Thebesian Veins: Demonstration by Contrast Enhanced Color Doppler. Echocardiography. 8(5). 527–532. 1 indexed citations
7.
Predel, Hans‐Georg, et al.. (1990). Atrial Natriuretic Peptide in Patients With Diabetes Mellitus Type I: Effects on Systemic and Renal Hemodynamics and Renal Excretory Function. American Journal of Hypertension. 3(9). 674–681. 12 indexed citations
8.
Weisser, Burkhard, E. Noack, Rainer Düsing, & K Glänzer. (1989). Assessment of beta-blocking activity of low-dose bupranolol.. PubMed. 9(1). 9–14. 1 indexed citations
9.
Kramer, Herbert J., et al.. (1985). Digoxin-Like Immunoreacting Substance(s) in the Serum of Patients with Chronic Uremia. ˜The œNephron journals/Nephron journals. 40(3). 297–302. 26 indexed citations
10.
Düsing, Rainer, et al.. (1984). Further studies on the mechanism of increased blood pressure during dietary linoleic acid deprivation.. PubMed. 16 Suppl 43. 103–8. 2 indexed citations
11.
Glänzer, K, et al.. (1984). Measurement of 8-arginine-vasopressin by radioimmunoassay Development and application to urine and plasma samples using one extraction method. European Journal of Endocrinology. 106(3). 317–329. 16 indexed citations
12.
Düsing, Rainer, et al.. (1983). Interaction of bemetizide and indomethacin in the kidney.. British Journal of Clinical Pharmacology. 16(4). 377–383. 6 indexed citations
13.
Glänzer, K, et al.. (1982). Hemodynamic and hormonal responses to 8-arginine-vasopressin in healthy man: Effects of indomethacin. Journal of Molecular Medicine. 60(19). 1234–1239. 19 indexed citations
14.
Düsing, Rainer, Roland Herrmann, K Glänzer, et al.. (1981). Renal Prostaglandins and Water Balance: Studies in Normal Volunteer Subjects and in Patients with Central Diabetes Insipidus. Clinical Science. 61(1). 61–67. 17 indexed citations
15.
Lüscher, Thomas F., H. Vetter, A. Studer, et al.. (1981). Renal venous renin activity in various forms of curable renal hypertension.. PubMed. 15(6). 314–20. 18 indexed citations
16.
Möhring, Jan, et al.. (1981). The antidiuretic hormone and arterial hypertension: recent observations in rats.. PubMed. 10. 75–87. 1 indexed citations
17.
Kramer, Holly, et al.. (1980). Immunoreactive Substance P in Human Plasma: Response to Changes in Posture and Sodium Balance. Clinical Science. 59(1). 75–77. 7 indexed citations
18.
Vetter, H., et al.. (1980). [Renin-angiotensin-aldosterone system in essential hypertension. Inappropriately high plasma aldosterone in young patients with severe hypertension and in older hypertensives].. PubMed. 110(50). 1938–41. 3 indexed citations
19.
Trübestein, G, et al.. (1979). [Fibrinolytic treatment with urokinase in older phlebothrombosis (author's transl)].. PubMed. 74(39). 1404–11. 1 indexed citations
20.
Glänzer, K, et al.. (1975). [Sputum examination in the diagnosis and treatment of chronic bronchitis (author's transl)].. PubMed. 29(6). 331–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by J. D. H. Slater Breakdown of academic impact, for papers by M. A. Barraclough Breakdown of academic impact, for papers by J. C. Romero Breakdown of academic impact, for papers by Schrier Rw Breakdown of academic impact, for papers by U. Fox Breakdown of academic impact, for papers by K. M. McDonald Breakdown of academic impact, for papers by J. C. Pelayo Breakdown of academic impact, for papers by K Horký Breakdown of academic impact, for papers by Yoram Shenker Breakdown of academic impact, for papers by F. Krück
Rankless by CCL
2026